Vadim V Ptushkin (Vadim Ptushkin, V V Ptushkin)

Publication Activity (10 Years)

Years Active: 2020-2023
Publications (10 Years): 14

Top Topics

Respiratory Syndrome Coronavirus

Ejection Fraction

Chronic Lymphocytic Leukemia

Top Venues

Terapevticheskii arkhiv

International journal of molecular sciences

Leukemia & lymphoma

Annals of hematology

This page only lists publications with an associated author ORCID identifier.

Publications

Eugene A Nikitin, Maria Kislova, Dmitry Morozov, Vera Belyakova, Anna Suvorova, Julia Sveshnikova, Galina Vyscub, Irina Matveeva, Maria Shirokova, Anna Shipaeva, Tatyana Klitochenko, Polina Makarovskaya, Elena A Dmitrieva, Bella Biderman, Andrey Borisovich Sudarikov, Tatiana N Obukhova, Olga Samoilova, Kamil Kaplanov, Tatyana Konstantinova, Olga Mayorova, Irina Poddubnaya, Vadim V Ptushkin
Ibrutinib in combination with rituximab is highly effective in treatment of chronic lymphocytic leukemia patients with steroid refractory and relapsed autoimmune cytopenias. Leukemia (2023)
Vadim V Ptushkin, Evgeniya Arshanskaya, Olga Vinogradova, Dmitry Anatolievich Kudlay, Eugene Nikitin
The Features of COVID-19's Course and the Efficacy of the Gam-COVID-Vac Vaccine in Patients with Paroxysmal Nocturnal Hemoglobinuria. Hematology reports 15 (3) (2023)
Alexey A Komissarov, Maria Kislova, Ivan A Molodtsov, Andrei A Petrenko, Elena Dmitrieva, Maria Okuneva, Iuliia O Peshkova, Naina T Shakirova, Daria M Potashnikova, Anna V Tvorogova, Vadim V Ptushkin, Grigory A Efimov, Eugene A Nikitin, Elena J Vasilieva
Coronavirus-Specific Antibody and T Cell Responses Developed after Sputnik V Vaccination in Patients with Chronic Lymphocytic Leukemia. International journal of molecular sciences 24 (1) (2022)
Alexey A Komissarov, Maria Kislova, Ivan A Molodtsov, Andrei A Petrenko, Elena Dmitrieva, Maria Okuneva, Iuliia O Peshkova, Naina T Shakirova, Daria M Potashnikova, Anna V Tvorogova, Vadim V Ptushkin, Grigory A Efimov, Eugene A Nikitin, Elena J Vasilieva
Coronavirus-Specific Antibody and T Cell Responses Developed after Sputnik V Vaccination in Patients with Chronic Lymphocytic Leukemia. International journal of molecular sciences 24 (1) (2022)
Alexey A Komissarov, Maria Kislova, Ivan A Molodtsov, Andrei A Petrenko, Elena Dmitrieva, Maria Okuneva, Iuliia O Peshkova, Naina T Shakirova, Daria M Potashnikova, Anna V Tvorogova, Vadim V Ptushkin, Grigory A Efimov, Eugene A Nikitin, Elena J Vasilieva
Coronavirus-Specific Antibody and T Cell Responses Developed after Sputnik V Vaccination in Patients with Chronic Lymphocytic Leukemia. International journal of molecular sciences 24 (1) (2022)
Alexey A Komissarov, Maria Kislova, Ivan A Molodtsov, Andrei A Petrenko, Elena Dmitrieva, Maria Okuneva, Iuliia O Peshkova, Naina T Shakirova, Daria M Potashnikova, Anna V Tvorogova, Vadim V Ptushkin, Grigory A Efimov, Eugene A Nikitin, Elena J Vasilieva
Coronavirus-Specific Antibody and T Cell Responses Developed after Sputnik V Vaccination in Patients with Chronic Lymphocytic Leukemia. International journal of molecular sciences 24 (1) (2022)
Оlga L Kochneva, Maria Kislova, Evgenya I Zhelnova, Andrei A Petrenko, Elena A Baryakh, Konstantin V Yatskov, Elena A Dmitrieva, Elena N Misurina, Konstantin E Nikitin, Elena J Vasilieva, Inna V Samsonova, Vadim V Ptushkin, Ancha Baranova, Eugene A Nikitin
COVID-19 in patients with chronic lymphocytic leukemia: a Moscow observational study. Leukemia & lymphoma 63 (7) (2022)
Vadim V Ptushkin, M A Kunst, Tatyana A Mitina, Tatyana S Konstantinova, N N Rachkova, T V Shelekhova, I V Elykomov, G B Kuchma, K O Farizova, Olga Vinogradova, Eugene A Nikitin, E D Pashanov
[Multiple myeloma: response to treatment and survival of patients according to the interim analysis of the Russian observational, retrospective-prospective, multicenter cohort study (MULTISPECT)]. Terapevticheskii arkhiv 94 (7) (2022)
V A Zherebtsova, Vladimir Vorobyev, E G Gemdzhian, M A Ulyanova, M V Chernikov, V L Ivanova, Olga Vinogradova, Vadim V Ptushkin
[Carfilzomib, lenalidomide and dexamethasone in relapsed/refractory multiple myeloma patients: the real-life experience]. Terapevticheskii arkhiv 93 (7) (2021)
Vladimir Vorobyev, E G Gemdzhian, Liudmila V Fedorova, N B Mikhailova, R K Ilyasov, L P Kaleikina, O S Trubyakova, Kamil D Kaplanov, E V Melnichenko, E V Martynova, E P Yakovleva, O Y Li, E V Tarasenko, E P Chumakova, N B Bulieva, E S Nesterova, O V Margolin, V A Zherebtsova, L S Butaev, Vadim V Ptushkin
[Five year experience in ibrutinib therapy for relapsed and refractory mantle cell lymphoma in real world Russian clinical practice]. Terapevticheskii arkhiv 93 (7) (2021)
Alexander Dmitrievich Kulagin, Vadim V Ptushkin, Elena A Lukina, Igor L Davydkin, Alexander V Korobkin, Vladimir S Shamrai, Tatyana S Konstantinova, Tatyana S Kaporskaya, Tatyana A Mitina, Tatyana I Ksenzova, Evgeny V Zuev, Oksana A Markova, Elena V Gapchenko, Dmitry Anatolievich Kudlay
Randomized multicenter noninferiority phase III clinical trial of the first biosimilar of eculizumab. Annals of hematology 100 (11) (2021)
Vadim V Ptushkin, M Mueller
[Analysis of the effectiveness of multiple myeloma treatment based on the clinical experience of European countries]. Terapevticheskii arkhiv 93 (4) (2021)
Alexander Dmitrievich Kulagin, Bulat A Bakirov, Igor L Davydkin, I V Elykomov, Tatyana S Konstantinova, Alexander V Korobkin, M V Kosinova, Vadim I Mazurov, N V Minaeva, A V Proidakov, Vadim V Ptushkin, Y V Shatokhin, Yulia N Linkova, Arina V Zinkina-Orikhan, Maria A Morozova
[The efficacy and safety of eculizumab biosimilar in patients with paroxysmal nocturnal hemoglobinuria. Results of a phase III randomized open-label comparative clinical trial]. Terapevticheskii arkhiv 93 (11) (2021)
Vadim V Ptushkin, Alexander Dmitrievich Kulagin, Elena A Lukina, Igor L Davydkin, Tatyana S Konstantinova, Vladimir S Shamrai, N V Minaeva, Dmitry Anatolievich Kudlay, Elena V Gapchenko, Oksana A Markova, A Y Borozinets
[Results of phase Ib open multicenter clinical trial of the safety, pharmacokinetics and pharmacodynamics of first biosimilar of eculizumab in untreated patients with paroxysmal nocturnal hemoglobinuria during induction of therapy]. Terapevticheskii arkhiv 92 (7) (2020)